Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byong H Kang

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 17, 2022
Correction to: Yeast Surface Display for Protein Engineering: Library Generation, Screening, and Affinity MaturationByong H Kang, Brianna M Lax, K Dane Wittrup
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2022
Yeast Surface Display for Protein Engineering: Library Generation, Screening, and Affinity MaturationByong H Kang, Brianna M Lax, K Dane Wittrup
Science Signaling|August 8, 2013
Simultaneous profiling of 194 distinct receptor transcripts in human cellsByong H Kang, Karin J Jensen, Jaime A Hatch, et al.
Plos One|April 15, 2021
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in miceByong H Kang, Noor Momin, Kelly D Moynihan, et al.
PNAS Nexus|January 30, 2023
Intratumoral nanobody-IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in miceEmi A Lutz, Noor Jailkhani, Noor Momin, et al.
Nature Communications|January 11, 2022
Maximizing response to intratumoral immunotherapy in mice by tuning local retentionNoor Momin, Joseph R Palmeri, Emi A Lutz, et al.
Nature Protocols|September 14, 2013
Isolation of human monoclonal antibodies from peripheral blood B cellsJinghe Huang, Nicole A Doria-Rose, Nancy S Longo, et al.
Blood|December 28, 2023
Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignanciesFrancesca Alvarez Calderon, Byong H Kang, Oleksandr Kyrysyuk, et al.
Mabs|May 10, 2026
Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safetyMatthew Siegel, Eric Zhu, Daniel Rios, et al.
Frontiers in Immunology|July 11, 2022
Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine MelanomaBeth E Grace, Coralie M Backlund, Duncan M Morgan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 17, 2022
Correction to: Yeast Surface Display for Protein Engineering: Library Generation, Screening, and Affinity MaturationByong H Kang, Brianna M Lax, K Dane Wittrup
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2022
Yeast Surface Display for Protein Engineering: Library Generation, Screening, and Affinity MaturationByong H Kang, Brianna M Lax, K Dane Wittrup
Science Signaling|August 8, 2013
Simultaneous profiling of 194 distinct receptor transcripts in human cellsByong H Kang, Karin J Jensen, Jaime A Hatch, et al.
Plos One|April 15, 2021
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in miceByong H Kang, Noor Momin, Kelly D Moynihan, et al.
PNAS Nexus|January 30, 2023
Intratumoral nanobody-IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in miceEmi A Lutz, Noor Jailkhani, Noor Momin, et al.
Nature Communications|January 11, 2022
Maximizing response to intratumoral immunotherapy in mice by tuning local retentionNoor Momin, Joseph R Palmeri, Emi A Lutz, et al.
Nature Protocols|September 14, 2013
Isolation of human monoclonal antibodies from peripheral blood B cellsJinghe Huang, Nicole A Doria-Rose, Nancy S Longo, et al.
Blood|December 28, 2023
Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignanciesFrancesca Alvarez Calderon, Byong H Kang, Oleksandr Kyrysyuk, et al.
Mabs|May 10, 2026
Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safetyMatthew Siegel, Eric Zhu, Daniel Rios, et al.
Frontiers in Immunology|July 11, 2022
Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine MelanomaBeth E Grace, Coralie M Backlund, Duncan M Morgan, et al.
Pageof 2